Navigation Links
SJF Ventures Completes Oversubscribed Series A Round for BioSurplus

DURHAM, N.C., and SAN DIEGO, July 17, 2012 /PRNewswire/ -- BioSurplus Inc., a leading provider of equipment management services and pre-owned laboratory instruments, announces the close of an oversubscribed Series A financing round with new funding from SJF Ventures.  The company raised a total of $2.4 million following a May investment from KI Investment Holdings.

With these investments, BioSurplus has expanded in Boston more quickly than anticipated.  The company will hold its first Boston auction of like-new used laboratory equipment from one of the most respected area distributors.  The equipment will be on display Aug. 13-14 from 10 a.m. to 6 p.m. at 56 Roland St. in Boston, with the online auction being held Aug. 15-22.  In addition, BioSurplus seeks qualified candidates to fill five new Boston positions in operations, sales, business development and tech support.

"SJF Ventures is pleased to support BioSurplus' growth and Boston expansion," said David Griest, Managing Director at SJF Ventures.  "The company is a market leader in an emerging sector of asset recovery, which fills a strategic position in our portfolio.  As the first investment of our third fund, BioSurplus aligns perfectly with our focus on capital efficient, growth stage companies offering proven solutions."

"Our oversubscribed Series A round and successful regional expansion illustrates that BioSurplus fills a very unique and underserved market need for used and refurbished lab equipment and related services," said Preston "Cinco" Plumb, President and CEO.  "We are delighted to partner with SJF Ventures and KI Investment Holdings, whose recent investments have put us months ahead of schedule for our Boston expansion and have positioned us for future growth."

About BioSurplus

Since 2002, BioSurplus has assembled a team of scientific experts to pioneer leading edge solutions for every stage of the lab equipment lifecycle.  From providing a website of dynamic inventory and online auctions, to developing software solutions that allow clients to manage their own equipment, to offering turnkey solutions for selling surplus assets, BioSurplus is dedicated to maximizing the value and use of laboratory equipment for its customers.  To this end, it has become a leading supplier of pre-owned laboratory instruments and equipment management services.

BioSurplus is headquartered in San Diego and has large showrooms in San Diego, the San Francisco Bay Area, Boston and Korea.  BioSurplus offers services nationally and sells equipment worldwide.  For more information, please visit the corporate website at

About SJF Ventures

SJF Ventures is a venture capital fund with offices in Durham, N.C., New York and San Francisco.  SJF has a 13-year successful record of assisting visionary and talented management teams in building industry-leading firms.  SJF provides strong expertise and networks in the cleantech, sustainability and technology enhanced services sectors; including particular experience in asset recovery, reuse and recycling with portfolio companies including eRecyclingCorps, Optoro, Salvage Direct, and Intechra.  For more information, visit

About KI Investment Holdings

KI Investment Holdings, LLC is an innovative investment firm, providing capital and expertise towards the goal of being instrumental in the long-term success of its portfolio companies.  For more information, visit

SOURCE BioSurplus
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Files Defamation Lawsuit
2. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
3. Pappas Ventures Names Pat Gage to Scientific Advisory Board
4. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
5. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
6. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
7. CryoLife Completes Acquisition of Hemosphere
8. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
9. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
10. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
11. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
Post Your Comments:
(Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Japanese Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... online platform for mental health and wellness consultation, has collaborated with a leading ... bridge the knowledge gap experienced by parents and bring advice from parenting experts ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):